2023 IS the Year for OTC Naloxone!
FDA Law Blog: Biosimilars
MARCH 29, 2023
While many states have had standing orders that allow for the dispensing of naloxone without an individual prescription, “harm reduction programs” that provide products and services to at-risk individuals still faced logistical difficulties in acquiring naloxone due to its prescription-only status which I discussed in this October 2022 blog post.
Let's personalize your content